| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |